Korean J Obstet Gynecol.  2008 Jul;51(7):771-776.

Fetal ductus arteriosus constriction and heart failure following maternal cyclooxygenase-2 inhibitor ingestion: A case report

Affiliations
  • 1Department of Obstetrics and Gynecology, College of Medicine, Chungnam National University, Daejeon, Korea. rheyun@cnu.ac.kr
  • 2Department of Pediatrics, College of Medicine, Chungnam National University, Daejeon, Korea.

Abstract

We report a case of premature constriction of the fetal ductus arteriosus following maternal ingestion of a cyclooxygenase-2 (COX-2) inhibitor at 37 weeks' gestation. Fetal sonography at 38+2 weeks' gestation revealed tricuspid regurgitation, absent transpulmonary valve flow, right heart enlargement, and pericardial effusion. An immediate delivery resulted in a good postnatal outcome with dramatic improvement in the clinical and echocardiographic findings. Maternal exposure to Non-steroidal anti-inflammatory drugs (NSAIDs), especially late in gestation, can cause premature constriction of the ductus arteriosus, heart failure, and fetal death. Therefore, the use of NSAIDs late in gestation should be considered in limited cases with close fetal heart monitoring.

Keyword

Ductus arteriosus; Non-steroidal anti-inflammatory drugs; Cyclooxygenase-2 inhibitor; Nimesulide

MeSH Terms

Anti-Inflammatory Agents, Non-Steroidal
Cardiomegaly
Constriction
Cyclooxygenase 2
Ductus Arteriosus
Eating
Female
Fetal Death
Fetal Heart
Heart
Heart Failure
Maternal Exposure
Pericardial Effusion
Pregnancy
Sulfonamides
Tricuspid Valve Insufficiency
Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase 2
Sulfonamides
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr